Ad
ECYT - Endocyte Stock Trading
About | Endocyte Inc. (NASDAQ:ECYT)
None
Quote | Endocyte Inc. (NASDAQ:ECYT)
| Last: | $ |
|---|---|
| Change Percent: | 0.00% |
| Open: | $N/A |
| Close: | $23.99 |
| High: | $N/A |
| Low: | $N/A |
| Volume: | 0 |
| Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Endocyte Inc. (NASDAQ:ECYT)
-
Clovis, a "trading stock," has some shakiness in its fundamentals. Moreover, the shares tend to rise and fall for you to trade for short-term gains. Due to upcoming catalysts in June, Clovis is a trading stock that is about to embark on another bullish cycle. Despite being a tradi...
-
I have been hesitant about buying into Progenics Pharmaceuticals ( PGNX ) due to my insufficient knowledge about the advancements of radiopharmaceuticals in the oncology arena. Perhaps it is all the hype of immuno-oncology and the rise of gene therapy that caused me to believe that radiopharma...
Message Board Posts | Endocyte Inc. (NASDAQ:ECYT)
| Subject | By | Source | When |
|---|---|---|---|
| Some serious money here | PennyStock Alert | investorshub | 09/17/2019 3:35:04 PM |
| I took short position. This has to pullback | PennyStock Alert | investorshub | 09/17/2019 1:51:27 PM |
| It isn't moving much. | BMM | investorshub | 10/22/2018 3:19:44 PM |
| Good buy here | dannyzee84 | investorshub | 10/19/2018 1:40:35 PM |
| ECYT buy 17.53 | stocktrademan | investorshub | 09/23/2018 11:01:23 PM |
Ad
-
Entered into agreement and plan of merger with Novartis AG for $2.1Billion WEST LAFAYETTE, Ind., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics...
-
WEST LAFAYETTE, Ind., Sept. 27, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced that the company’s management team will present at two upcoming investor conferences ...